BML Capital Management as of March 31, 2025
Portfolio Holdings for BML Capital Management
BML Capital Management holds 27 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Atea Pharmaceuticals (AVIR) | 18.4 | $23M | 7.6M | 2.99 | |
| Aclaris Therapeutics (ACRS) | 17.6 | $22M | 14M | 1.53 | |
| Third Harmonic Bio (THRD) | 10.7 | $13M | 3.8M | 3.47 | |
| Adverum Biotechnologies Com New (ADVM) | 9.7 | $12M | 2.7M | 4.37 | |
| An2 Therapeutics (ANTX) | 6.3 | $7.8M | 5.7M | 1.36 | |
| Instil Bio Com New (TIL) | 5.9 | $7.2M | 417k | 17.36 | |
| Essa Pharma Com New (EPIX) | 5.4 | $6.7M | 4.2M | 1.58 | |
| Oramed Pharmaceuticals Com New (ORMP) | 5.2 | $6.5M | 3.0M | 2.14 | |
| Ikena Oncology (IKNA) | 3.8 | $4.7M | 3.7M | 1.28 | |
| Pmv Pharmaceuticals (PMVP) | 3.3 | $4.1M | 3.7M | 1.09 | |
| Aadi Bioscience (WHWK) | 2.7 | $3.4M | 1.9M | 1.78 | |
| Lava Therapeutics Nv SHS (LVTX) | 2.0 | $2.5M | 2.0M | 1.27 | |
| Kezar Life Sciences Com New (KZR) | 1.6 | $2.0M | 408k | 4.88 | |
| Elevation Oncology (ELEV) | 1.2 | $1.5M | 5.9M | 0.26 | |
| Astrotech Corp (ASTC) | 1.2 | $1.4M | 220k | 6.48 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.9 | $1.2M | 2.1M | 0.55 | |
| Sage Therapeutics (SAGE) | 0.9 | $1.1M | 135k | 7.95 | |
| Athira Pharma (ATHA) | 0.7 | $912k | 3.2M | 0.28 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $909k | 1.1M | 0.80 | |
| Lisata Therapeutics (LSTA) | 0.4 | $510k | 217k | 2.35 | |
| Turnstone Biologics Corp (TSBX) | 0.4 | $452k | 1.1M | 0.41 | |
| Vistagen Therapeutics Ord (VTGN) | 0.3 | $375k | 150k | 2.50 | |
| Alumis (ALMS) | 0.2 | $305k | 50k | 6.14 | |
| Nextcure (NXTC) | 0.1 | $131k | 274k | 0.48 | |
| Verrica Pharmaceuticals | 0.1 | $77k | 175k | 0.44 | |
| Hillevax | 0.0 | $30k | 21k | 1.45 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.0 | $0 | 3.8M | 0.00 |
